Clinical Trial

Effectiveness of the Personalized Responses & Integrated Systems for Metabolism (PRISM) on Improving Insulin Resistance Among Adults With Metabolic Syndrome: A Pilot Study (PRISM-I)

Study acronym: PRISM-I
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the Personalized Responses \& Integrated Systems for Metabolism (PRISM-I) pilot study is to assess the feasibility of conducting a definitive randomized controlled trial evaluating precision lifestyle interventions for improving insulin resistance in adults with metabolic syndrome.
Trial Details
NCT Number NCT07710274
Lead Sponsor National University Health System, Singapore
Conditions Metabolic Syndrome (MetS)
Enrollment 200 participants
Start Date 2026-07
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-17